Description

Buy Mydekla Online, which is an antiviral drug used for treating hepatitis C virus infection. Daclatasvir 60 mg is a combination that treats chronic hepatitis C infection. Daclatasvir Tablets may also be used in combination with sofosbuvir. Mydekla 60 mg is not advised for use in patients with a history of infection with hepatitis B due to the increased risk of serious adverse reactions. Adults with or without cirrhosis who have genotype 1 or genotype 3 chronic hepatitis C are treated with mydekla.

How to Use Mydekla 60 mg?

The patient is advised to take Mydekla 60 mg as per the doctor’s prescribed time and dose. You cannot chew or crush it. Instead, you have to swallow it whole Daclatasvir 60 mg to be taken at a fixed time. You should drink a lot of fluid and eat a healthy diet to prevent its side effects. Please consult a doctor if you are pregnant or trying to conceive or breastfeeding.

Side Effects of Daclatasvir 60 mg:

Several side effects of Mydekla 60 mg anemia, sleep disturbances, mental confusion, chest pain, memory problems, unusual tiredness, headache, diarrhea, severe skin rash, dizziness, and shortness of breath.

Other Available Substitutes:

• Natdac 30mg Tablet
• Natdac 60mg Tablet
• Daclahep 60mg Tablet

FAQS:

How does Mydekla 60 work? 

Mydekla 60 works by targeting and inhibiting the action of a protein called NS5A, which is essential for the replication of the hepatitis C virus. By blocking this protein, Mydekla 60 helps prevent the virus from multiplying and spreading in the body, thus reducing the viral load and improving liver function.

Can I use Daclatasvir 60 with other medications? 

Mydekla 60 can interact with certain medications, including antiretroviral drugs, antimicrobial agents, and certain cardiovascular medications. It is important to inform your doctor about all the medications, supplements, and herbal products you are taking to avoid potential drug interactions.

How effective is Mydekla 60 in treating hepatitis C? 

Mydekla 60, in combination with other antiviral medications, has shown high rates of effectiveness in treating chronic hepatitis C virus (HCV) infection. However, the efficacy can vary depending on factors such as the genotype of the virus, prior treatment history, and individual patient characteristics.